April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Tesla: Rebound Signals Strength Amid Economic Shifts
3M: Evaluating Challenges to Portfolio Resilience
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
RenovoRx (RNXT) stock forecast for 2026
Updated: April 24, 2025 (19:42)
Sector: HealthcareThe share price of RenovoRx, Inc. (RNXT) now
50/200 Day Moving Average: $0.976 / $1.122
This figure corresponds to the Average Price over the previous 50/200 days. For RenovoRx stocks, the 50-day moving average is the resistance level today.
For RenovoRx stocks, the 200-day moving average is the resistance level today.
Are you interested in RenovoRx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the RenovoRx stock price in 2026. How much will one RenovoRx share be worth in 2026? Is it worth taking profit / loss on RNXT stock now or waiting? What are analysts' forecasts for RenovoRx stock?
We forecast RenovoRx stock performance using neural networks based on historical data on RNXT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
RenovoRx, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for RenovoRx analysts is $4.875. Today 200 Day Moving Average is the resistance level (1.122 $). 50 Day Moving Average is the support level (0.976 $).
Historical and forecast chart of RenovoRx, Inc. stock
The chart below shows the historical price of RenovoRx stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the RNXT stock price can be found in the table below.
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. Its therapy platform, RenovoRx, handles the optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
RenovoRx (RNXT) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.12 | 1.03 | 1.22 | 14.92 % |
| Feb | 1.20 | 1.15 | 1.38 | 16.90 % |
| Mar | 1.22 | 1.10 | 1.38 | 20.21 % |
| Apr | 1.08 | 0.95 | 1.17 | 18.60 % |
| May | 1.28 | 1.16 | 1.38 | 15.99 % |
| Jun | 1.42 | 1.32 | 1.49 | 11.60 % |
| Jul | 1.51 | 1.34 | 1.60 | 16.07 % |
| Aug | 1.57 | 1.48 | 1.77 | 16.34 % |
| Sep | 1.51 | 1.40 | 1.60 | 12.12 % |
| Oct | 1.42 | 1.31 | 1.61 | 18.95 % |
| Nov | 1.65 | 1.51 | 1.75 | 13.45 % |
| Dec | 1.49 | 1.28 | 1.61 | 20.52 % |
RenovoRx information and performance
333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA, US
Market capitalization of the RenovoRx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RNXT shares in the company outstanding by the market price of one share.
EBITDA of RenovoRx is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
RenovoRx price target for 2026 by month
Target values for the price of one RenovoRx share for Jan 2026.
In Jan, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 14.917% volatility is expected.
Pessimistic target level: 1.03
Optimistic target level: 1.22
Target values for the price of one RenovoRx share for Feb 2026.
In Feb, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 16.899% volatility is expected.
Pessimistic target level: 1.15
Optimistic target level: 1.38
Target values for the price of one RenovoRx share for Mar 2026.
In Mar, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 20.212% volatility is expected.
Pessimistic target level: 1.10
Optimistic target level: 1.38
Target values for the price of one RenovoRx share for Apr 2026.
In Apr, the Negative dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 18.600% volatility is expected.
Pessimistic target level: 0.95
Optimistic target level: 1.17
Target values for the price of one RenovoRx share for May 2026.
In May, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 15.986% volatility is expected.
Pessimistic target level: 1.16
Optimistic target level: 1.38
Target values for the price of one RenovoRx share for Jun 2026.
In Jun, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 11.597% volatility is expected.
Pessimistic target level: 1.32
Optimistic target level: 1.49
Target values for the price of one RenovoRx share for Jul 2026.
In Jul, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 16.068% volatility is expected.
Pessimistic target level: 1.34
Optimistic target level: 1.60
Target values for the price of one RenovoRx share for Aug 2026.
In Aug, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 16.341% volatility is expected.
Pessimistic target level: 1.48
Optimistic target level: 1.77
Target values for the price of one RenovoRx share for Sep 2026.
In Sep, the Negative dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 12.121% volatility is expected.
Pessimistic target level: 1.40
Optimistic target level: 1.60
Target values for the price of one RenovoRx share for Oct 2026.
In Oct, the Negative dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 18.947% volatility is expected.
Pessimistic target level: 1.31
Optimistic target level: 1.61
Target values for the price of one RenovoRx share for Nov 2026.
In Nov, the Positive dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 13.447% volatility is expected.
Pessimistic target level: 1.51
Optimistic target level: 1.75
Target values for the price of one RenovoRx share for Dec 2026.
In Dec, the Negative dynamics for RenovoRx, Inc. shares will prevail with possible monthly volatility of 20.518% volatility is expected.
Pessimistic target level: 1.28
Optimistic target level: 1.61
Related stocks from Healthcare sector
